跳至主要内容
临床试验/CTRI/2020/02/023123
CTRI/2020/02/023123已完成4 期

Efficacy of Shallakyadi capsule in the prevention of post chikungunya chronic inflammatory rheumatism-a prospective cohort study

Institute for Post Graduate Teaching and Research in Ayurveda Gujarat Ayurved University Jamnagar0 个研究点目标入组 90 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Age between 18 years to 60 years of either sex.
  • Confirm case of Chikungunya fever
  • Patient willing to participate in the trial.

排除标准

  • Age below 18 years & above 60 years.
  • ? Pregnant and lactating women
  • ? History of RA, Gout, Psoriatic arthritis, rheumatic fever, autoimmune disease, thyroid
  • dysfunction, sarcoidosis, SLE before Chikungunya fever.
  • ? Patients suffering from: Malignant and accelerated hypertension, coronary artery
  • disease, uncontrolled diabetes.
  • ? Patient undergoing regular treatment for any other severe illness and also patients
  • suffering from pulmonary tuberculosis or bone tuberculosis, carcinoma and HIV positive

研究者

发起方
Institute for Post Graduate Teaching and Research in Ayurveda Gujarat Ayurved University Jamnagar

相似试验